Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Alessandra Tedeschi et al.|New England Journal of Medicine|2015Cited by 1.6k
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program StudyZijun Y. Xu‐Monette, Ken H. Young, Eric D. Hsi et al.|Blood|2012Cited by 390
miR-17-92 cluster microRNAs confers tumorigenicity in multiple myelomaLijuan Chen, Jianyong Li, Chunming Li et al.|Cancer Letters|2011Cited by 119
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid LeukemiaMei Guo, Nelson J. Chao, Jianyong Li et al.|JAMA Oncology|2017Cited by 48
The distinct clinical features and prognosis of the CD10+MUM1+ and CD10−Bcl6−MUM1− diffuse large B-cell lymphomaTingxun Lu, Jianyong Li|Scientific Reports|2016Cited by 42